ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $128,000 | +93.9% | 106,772 | +70.4% | 0.00% | +100.0% |
| Q1 2015 | $66,000 | +10.0% | 62,647 | +13.5% | 0.00% | 0.0% |
| Q4 2014 | $60,000 | +36.4% | 55,204 | +35.6% | 0.00% | 0.0% |
| Q3 2014 | $44,000 | +12.8% | 40,703 | +9.8% | 0.00% | 0.0% |
| Q2 2014 | $39,000 | +116.7% | 37,056 | +112.7% | 0.00% | – |
| Q1 2014 | $18,000 | -57.1% | 17,421 | -52.2% | 0.00% | – |
| Q4 2013 | $42,000 | +10.5% | 36,443 | +62.9% | 0.00% | – |
| Q3 2013 | $38,000 | – | 22,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |